Sanara MedTech Inc.
SMTI
$33.95
$3.4311.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.14% | 26.42% | 48.70% | 35.24% | 27.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.14% | 26.42% | 48.70% | 35.24% | 27.97% |
| Cost of Revenue | -3.55% | -2.91% | 25.78% | 13.74% | -8.17% |
| Gross Profit | 31.64% | 29.75% | 51.28% | 37.87% | 33.80% |
| SG&A Expenses | 13.69% | 32.41% | 34.02% | 33.76% | 37.26% |
| Depreciation & Amortization | 0.79% | 1.72% | 0.62% | 10.64% | 37.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.16% | 26.72% | 39.18% | 30.69% | 28.24% |
| Operating Income | 98.92% | -30.21% | 38.03% | 15.20% | -30.17% |
| Income Before Tax | 42.81% | -96.08% | -548.09% | -163.32% | -89.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.81% | -96.08% | -548.09% | -163.32% | -89.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -84.13% | -99.43% | 540.32% | -26.88% | -34.38% |
| Net Income | 42.51% | -99.93% | -548.65% | -169.50% | -91.72% |
| EBIT | 98.92% | -30.21% | 38.03% | 15.20% | -30.17% |
| EBITDA | 160.39% | -94.23% | 76.99% | 58.83% | -26.01% |
| EPS Basic | 43.48% | -96.47% | -537.10% | -163.55% | -86.23% |
| Normalized Basic EPS | 43.52% | -92.03% | 2.15% | -28.74% | -57.14% |
| EPS Diluted | 43.48% | -96.47% | -537.10% | -163.55% | -86.23% |
| Normalized Diluted EPS | 43.52% | -92.03% | 2.15% | -28.74% | -57.14% |
| Average Basic Shares Outstanding | 1.70% | 1.79% | 1.78% | 2.22% | 2.95% |
| Average Diluted Shares Outstanding | 1.70% | 1.79% | 1.78% | 2.22% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |